Abingworth LLP, 10% Owner at Jasper Therapeutics, Inc. (JSPR), bought 190,000 shares at $12.95 ($2.5M) on 2024-02-08, disclosed to the SEC on 2024-02-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| VERA | BUY | 2021-05-18 | $8.5M | — | Filing → |
| PSNL | SELL | 2020-10-21 | $7.2M | — | Filing → |
| PSNL | SELL | 2020-10-20 | $16.0M | — | Filing → |